(NASDAQ: EYEN) (“Eyenovia” or the “Company”), an ophthalmic technology company focused on completing development of its proprietary Optejet topical ophthalmic medication dispensing platform, today ...
The Company's Board of Directors approved the reverse stock split at a ratio of 1-for-150 shares on January 25, 2025, following approval for the action by Crown's stockholders at a special ...
ZK International Group (ZKIN) announces 1-for-7 reverse stock split to meet NASDAQ listing requirements, effective Jan.
The Reverse Stock Split will become effective at 12:01 a.m. Eastern Time on Friday, December 27, 2024, and the Company's Common Share will commence trading on the Nasdaq Capital Market on a post ...
The reverse stock split aims to help Cara Therapeutics regain compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market. Following the reverse stock ...